证券代码：002044 证券简称：美年健康 公告编号：2025-055 美年大健康产业控股股份有限公司 关于公司及下属子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 美年大健康产业控股股份有限公司（以下简称"公司"或"美年健康"）于 2024 年 12 月 13 日召开第九届董事会第五次（临时）会议及 2024 年 12 月 30 日召开 2024 年第六次临时股东大会，审议通过《关于公司及下属子公司申请融资额度并 提供担保的议案》，同意公司及部分下属子公司 2025 年度为公司及合并报表范围 内的子公司提供担保额度累计不超过人民币 49 亿元。具体内容详见公司于 2024 年 12 月 14 日在巨潮资讯网（www.cninfo.com.cn）披露的《关于公司及下属子公 司申请融资额度并提供担保的公告》（公告编号：2024-111）。 二、进展情况 有限公司（以下简称"抚州美年"）、上海美锦门诊部有限公司（以下简称"上海美 锦"）、慈铭健康体检管理集团南京有限公司（以下简称"慈铭南京"）分别提供融 资本金人民币 7 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300149 | 睿智医药 | 13.30 | -6.60% | 97.13万 | 13.47 乙 | | 688710 | 益诺思 | 42.93 | -4.34% | 2.77万 | 1.21亿 | | 300725 | 药石科技 | 47.25 | -4.08% | 22.57万 | 10.92亿 | | 603456 | 九州药业 | 18.32 | -3.48% | 63.91万 | 11.90亿 | | 603259 | 药明康德 | 93.00 | -3.40% | 89.33万 | 83.98亿 | | 300759 | 康龙化成 | 30.10 | -3.22% | 61.22万 | 18.70亿 | | 688202 | 美迪西 | 61.60 | -2.84% | 7.28万 | 4.55 Z | | 002173 | 创新医疗 | 14.92 | -2.74% | 81.94万 | 12.53亿 | | 002821 | 司 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Meinian Health, which closed at 5.22 yuan with a PE ratio of 69.61, marking a new low in 26 days, and a total market capitalization of 20.432 billion yuan [1][2] - The average PE ratio for the healthcare services industry is 47.90, with a median of 59.27, positioning Meinian Health at 34th place within the industry [1][2] - As of the first quarter of 2025, 24 institutions hold shares in Meinian Health, with a total of 175.92 million shares valued at 904 million yuan [1] Group 2 - Meinian Health's main business is health examination services, with the primary product being health check-up services [1] - The latest financial results for the first quarter of 2025 show a revenue of 1.754 billion yuan, a year-on-year decrease of 2.62%, and a net profit of -275.34 million yuan, reflecting a year-on-year increase of 3.94%, with a gross profit margin of 24.04% [1]

Core Insights - The collaboration between Meinian Health and Shenzhen Luohu District People's Hospital aims to enhance medical services through complementary strengths, focusing on patient convenience and joint development [1][3]. Group 1: Collaboration Details - The partnership will facilitate seamless referrals and green channel services, allowing clients to access high-quality medical resources at Shenzhen Luohu District People's Hospital [2][3]. - The hospital will assign dedicated personnel to coordinate referrals and surgical services for Meinian Health clients, ensuring smooth processes [3]. Group 2: Specialized Medical Services - The collaboration will leverage the hospital's expertise in diagnosing and treating conditions such as lung nodules and varicose veins, providing specialized services to Meinian Health clients [2][4]. - The integration of services aims to create a one-stop solution for patients, streamlining the process from screening to diagnosis and treatment [2][4]. Group 3: Future Prospects - Meinian Health plans to continue exploring innovative medical service models in partnership with Shenzhen Luohu District People's Hospital, enhancing the overall healthcare experience for residents [4].

Core Insights - The collaboration between Meinian Health and Shenzhen Luohu District People's Hospital aims to enhance medical services through complementary strengths, focusing on patient referrals and green channel services [1][2][3] Group 1: Collaboration Details - The partnership will facilitate seamless patient referrals to the hospital, allowing clients to access high-quality medical resources [2][3] - The hospital will assign dedicated personnel to coordinate referral processes and ensure smooth transitions for patients from Meinian Health [3] Group 2: Specialized Medical Services - The collaboration will leverage the hospital's expertise in treating conditions such as lung nodules and varicose veins, providing specialized diagnostic and treatment pathways [2][3] - Meinian Health will benefit from the hospital's advanced medical technologies and services, enhancing the overall patient experience [4] Group 3: Future Prospects - Both parties express intentions to explore further innovative healthcare service models, aiming to deepen the integration of health management and medical services [4]

Core Viewpoint - Meinian Health's stock price closed at 5.04 yuan on July 30, 2025, reflecting a decline of 1.18% from the previous trading day, with a trading volume of 4.35 billion yuan [1] Company Overview - Meinian Health operates in the healthcare services industry, specializing in health check-ups and medical services, including health examinations, health management, and medical consulting [1] Recent Developments - The company has recently received a new business license from the Zhejiang Provincial Market Supervision Administration, following the approval of related amendments by the board of directors and the shareholders' meeting [1] Financial Activity - On July 30, the net inflow of main funds into Meinian Health was 193,400 yuan [1]

Group 1 - The company announced the convening of the 10th (temporary) meeting of the 9th Board of Directors on July 11, 2025, and the first temporary shareholders' meeting on July 28, 2025, to review the proposal for amendments [2] - The company has recently received a new business license issued by the Zhejiang Provincial Market Supervision Administration [2]

一篇《女律师十年体检未有"患癌风险"预警，确诊已是肾癌晚期》的文章，正在将体检行业龙头爱康国宾拖入舆论的风暴，而这场风波也再次让公众对整 个民营体检行业守护健康的价值，产生严重的质疑。 舆论压力之下，爱康国宾在7月30日举行了媒体说明会。 而爱康集团创始人、董事长兼CEO张黎刚对此称，"大家想一下，大多数企业给员工做个体检，少的几百块，钱多的也就几千块钱，大家去医院看个病， 你要诊断某个病，你们问问自己，大概要花多少钱。当你指望说，一个几百块钱的体检能帮你什么病都查出来，而要查单一的病，多花几千几万块钱的时 候，你认为这样的情况存在吗?至于这样的模糊的原因，就是因为我们公众对于体检与看病，没有明确的边界，导致公众对体检有很多误解。" 此番回应，不仅让爱康国宾陷入巨大争议，更是再度将民营体检行业推上了口碑近乎崩盘的风口浪尖。 回到事件本身。从2013 年到 2023 年，女律师张晓玲在爱康国宾完成了十年体检，所有报告均显示 "正常"。直到 2024 年，她在其他医院被确诊癌症晚 期，历经九个月跨国治疗，付出了失去一个肾和腰椎终"右肾钙化灶"。回想2023年那次体检，张女士的报告已经提示了右肾钙化，她特意询问工作 ...

近日，公司收到浙江省市场监督管理局换发的《营业执照》。变更后公司登记 备案的相关信息如下： 名称：美年大健康产业控股股份有限公司 类型：股份有限公司（上市） 住所：浙江省绍兴市柯桥区华舍街道中纺时代大厦 0112 室 证券代码：002044 证券简称：美年健康 公告编号：2025-054 美年大健康产业控股股份有限公司 关于公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 美年大健康产业控股股份有限公司（以下简称"公司"）于 2025 年 7 月 11 日 召开第九届董事会第十次（临时）会议及 2025 年 7 月 28 日召开 2025 年第一次临 时股东大会，审议通过《关于修订<公司章程>的议案》。详见公司在巨潮资讯网 （www.cninfo.com.cn）披露的《关于修订<公司章程>的公告》（公告编号：2025- 043）及《2025 年第一次临时股东大会决议公告》（公告编号：2025-052）。 经营范围：从事医疗技术专业领域内的技术开发、技术咨询、技术转让、技术 服务；投资管理；健康管理咨询（不得从事医疗活动、心理咨询）；设 ...

Core Viewpoint - The major shareholder of Meinian Health Industry Holdings Co., Ltd., Hangzhou Xintou Information Technology Co., Ltd., has reduced its stake in the company from 11.81% to 10.88% through a series of transactions between July 23 and July 28, 2025, involving a total of 36,579,778 shares [1]. Group 1 - Hangzhou Xintou Information Technology Co., Ltd. executed a reduction of its shareholding in Meinian Health, impacting its ownership percentage significantly [1]. - The reduction in shareholding was disclosed in a pre-announcement on May 6, 2025, indicating compliance with information disclosure obligations [1]. - The reduction of shares has reached a threshold of 1% of Meinian Health's total share capital [1].